BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30410549)

  • 1. Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
    de Silva R; Dasanayake D; Senanayake M; Ediriweera R; Dias S; Karunatilleke C; Brocas K; Tahami F; Seneviratne S
    Allergy Asthma Clin Immunol; 2018; 14():70. PubMed ID: 30410549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
    Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
    Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Role of
    Moffitt K; Cheung E; Manis J; Malley R
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric hyperimmunoglobulin E syndrome (Job's syndrome) with STAT3 mutation: A case report.
    Bhutani N; Sharma U; Kumar A; Kajal P
    Ann Med Surg (Lond); 2021 Jun; 66():102452. PubMed ID: 34141423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
    Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
    J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Profile of Hyper-IgE Syndrome in India.
    Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
    Front Immunol; 2021; 12():626593. PubMed ID: 33717144
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
    Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
    Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 mutations in the hyper-IgE syndrome.
    Holland SM; DeLeo FR; Elloumi HZ; Hsu AP; Uzel G; Brodsky N; Freeman AF; Demidowich A; Davis J; Turner ML; Anderson VL; Darnell DN; Welch PA; Kuhns DB; Frucht DM; Malech HL; Gallin JI; Kobayashi SD; Whitney AR; Voyich JM; Musser JM; Woellner C; Schäffer AA; Puck JM; Grimbacher B
    N Engl J Med; 2007 Oct; 357(16):1608-19. PubMed ID: 17881745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome.
    Tar I; Szegedi M; Krasuska-Sławińska E; Heropolitańska-Pliszka E; Bernatowska EA; Öncü E; Keles S; Guner SN; Reisli I; Gesheva N; Naumova E; Izakovicova-Holla L; Litzman J; Savchak I; Kostyuchenko L; Erdõs M
    Cent Eur J Immunol; 2023; 48(3):228-236. PubMed ID: 37901871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
    Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
    J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
    Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
    Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
    Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
    J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
    Freeman AF; Domingo DL; Holland SM
    Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
    Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
    J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
    Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
    Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
    Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
    Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Unexpected Infection in Loss-of-Function Mutations in STAT3: Malignant Alveolar Echinococcosis in Liver.
    Haskologlu S; Dogu F; Gollu Bahadır G; Akyuzluer S; Ciftci E; Altun D; Keles S; Kologlu M; Ikinciogullari A
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):667-675. PubMed ID: 33463136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of hyper IgE syndrome.
    Heimall J; Freeman A; Holland SM
    Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.